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The pathophysiological mechanisms underlying preserved left ventricular (LV) ejection
fraction (EF) in patients with heart failure and preserved ejection fraction (HFpEF)
remain incompletely understood. We hypothesized that transmural variations in myofiber
contractility with existence of subendocardial dysfunction and compensatory increased
subepicardial contractility may underlie preservation of LVEF in patients with HFpEF. We
quantified alterations in myocardial function in a mathematical model of the human LV
that is based on the finite element method. The fiber-reinforced material formulation of
the myocardium included passive and active properties. The passive material properties
were determined such that the diastolic pressure-volume behavior of the LV was similar to
that shown in published clinical studies of pressure-volume curves. To examine changes
in active properties, we considered six scenarios: (1) normal properties throughout the
LV wall; (2) decreased myocardial contractility in the subendocardium; (3) increased
myocardial contractility in the subepicardium; (4) myocardial contractility decreased
equally in all layers, (5) myocardial contractility decreased in the midmyocardium
and subepicardium, (6) myocardial contractility decreased in the subepicardium. Our
results indicate that decreased subendocardial contractility reduced LVEF from 53.2
to 40.5%. Increased contractility in the subepicardium recovered LVEF from 40.5 to
53.2%. Decreased contractility transmurally reduced LVEF and could not be recovered
if subepicardial and midmyocardial contractility remained depressed. The computational
results simulating the effects of transmural alterations in the ventricular tissue replicate
the phenotypic patterns of LV dysfunction observed in clinical practice. In particular,
data for LVEF, strain and displacement are consistent with previous clinical observations
in patients with HFpEF, and substantiate the hypothesis that increased subepicardial
contractility may compensate for subendocardial dysfunction and play a vital role in
maintaining LVEF.
Keywords: heart failure and preserved ejection fraction, left ventricle, myocardial contractility, finite element
method, simulation
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INTRODUCTION
Heart Failure (HF) is the only cardiovascular disease for which
incidence, prevalence, morbidity, mortality, and costs are not
decreasing. According to the 2017Update (Benjamin et al., 2017),
the prevalence of HF has increased from 5.7 million (2009 to
2012) to 6.5 million (2011 to 2014) in Americans >20 years
of age and projections show prevalence will increase 46% by
2030, resulting in over 8 million adults with HF (Heidenreich
et al., 2013). In 2012, the total cost for HF was estimated to
be $31 billion and projections show that by 2030, the total
cost will increase to $70 billion or roughly ∼$244 for every US
adult (Heidenreich et al., 2013). Among patients hospitalized
for an HF incident, 47% had HF with preserved ejection
fraction (HFpEF) or systolic function, which is the focus of this
paper.
The mechanism of the development of HFpEF is not
well-understood (Aurigemma and Gaasch, 2004; Shah and
Solomon, 2012; Steinberg et al., 2012; Sengupta and Marwick,
2018), and optimal treatment options remain unclear (Vasan
et al., 1995; Bhuiyan and Maurer, 2011). Recent studies have
suggested that HFpEF is associated with transmural changes in
myocardial deformation (Shah and Solomon, 2012; Omar et al.,
2016, 2017). Understanding the transmural variations in left
ventricular (LV) mechanics associated with HFpEF may offer
pathophysiological insights for developing potential therapeutic
targets. We therefore explored a physics-based mathematical
[finite element (FE)] model of the normal human LV to test the
hypothesis that reduced subendocardial contractility combined
with compensatory high subepicardial contractility may help in
preserving LVEF independent of changes inmyocardial geometry
and material properties. We used our established computational
framework in this paper. To the best of our knowledge, this is
the first study that quantifies the development of HFpEF based
on transmural variation in contractility, using patient-specific
parameters.
METHODS
Patient Data
In vivo echocardiographic recordings were obtained under a
protocol approved by our institutional review board. Individual
patients provided informed consent and anonymized data were
sent to a core laboratory for analysis.
Geometry Considerations
The ventricle model pertains to a normal human subject. The
LV was modeled as a truncated thick-walled ellipsoid (Mercier
et al., 1982; LeGrice et al., 2001). Based on echocardiography
recordings for end diastolic volume (EDV), LV diameter and wall
thicknesses for the posterior and septal wall, we back-calculated
ellipsoidal surfaces for the endocardium and epicardium at end
diastole (ED).
Using a linearly regressed estimation of the unloaded LV cavity
volume V0 (Klotz et al., 2006) we scaled the dimensions of
the endocardium surface to match the calculated volume V0.
The epicardium dimensions were then scaled to maintain the
samemyocardial wall volume ascertained at the ED configuration
(preservation of mass).
TruGrid (XYZ Scientific Applications Inc, Pleasant Hill,
California, USA) was used to mesh LV surfaces. The ventricle
was meshed to produce eight layers through the radial direction
(Figure 1). Finite element calculations were performed in
ABAQUS (SIMULIA, Providence, RI, USA). The FE meshes are
shown in Figure 1.
We used a rule-based approach coded in MATLAB 2012b
(The MathWorks, Inc., Natick, Massachusetts, United States) to
assign myofiber orientations to the centroid of each element in
the meshed LV geometry. The aggregated myofiber orientation
was assumed to present with an angle of −60◦ from the local
circumferential direction on the epicardium surface that varies
linearly through the LV wall thickness to an angle of +60◦ on
the endocardial surface. This assumption is well-established in
LV modeling studies (Carrick et al., 2012; Lee et al., 2013, 2015;
Genet et al., 2014), and based on histological studies (Streeter
et al., 1969), and diffusion tensor MRI studies (Lombaert et al.,
2011).
Constitutive Equation and Material
Parameters
The material formulation of the LV tissue includes passive and
active properties. The passive behavior of the tissue was described
using the model introduced by Holzapfel and Ogden (Holzapfel
and Ogden, 2009; Göktepe et al., 2011). Briefly, the strain
energy function used to compute passive stresses is composed of
FIGURE 1 | In normal conditions, contractility (Tmax) was uniform in all layers
(scenario 1). To simulate no contraction in the subendocardial region,
contractility in three layers in white was set to zero (scenario 2). The three
layers in red were used to simulate alterations in subepicardial contractility
(scenario 3). The three white layers, the two green layers, and the three red
layers comprise subendocardial, midmyocardial, and subepicardial regions,
respectively.
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deviatoric (9dev) and volumetric (9vol) parts as follows:
9dev =
a
2b
eb(l1−3) +
∑
i=f ,s
ai
2bi
{
ebi(l4i−1)
2
− 1
}
+
afs
2bfs
{
ebfs
(
l8fs
)2
− 1
}
(1)
9vol =
1
D
(
J2 − 1
2
− ln (J))
where a and b represent isotropic stiffness of the tissue, af and
bf represent tissue stiffness in the fiber direction, and afs and bfs
represent the stiffness resultant from connection between fiber
and sheet directions; l1, l4i, and l8fs are invariants, defined as
follows:
l1 : = tr(C)
l4i : = C :(f0 ⊗ f0)
l8fs : = C : sym(f0 ⊗ s0)
where C is the right Cauchy-Green tensor, and f0 and s0 are
vectors specifying the fiber and sheet directions, respectively. J
is the deformation gradient invariant, and D is a multiple of the
Bulk Modulus K (i.e., D = 2/K).
The material constants a, ai, and afs scale the strain-stress
curve, whereas material constants b, bi, and bfs determine the
shape of the strain-stress curve. To determine these parameters
we used the End Diastolic Pressure Volume (ED PV) curve as
described by Klotz et al. who reported an analytical expression for
the ED PV curve based on a single PV point that is applicable for
multiple species, including humans (Klotz et al., 2006). The LV
EDV of 53ml was recorded using echocardiography and the LV
EDP of 14.3 mmHg was approximated from echocardiography
data using Nagueh’s formula (Nagueh et al., 1997).
The optimized material properties were found using an in-
house Python script that minimized the error between the ED
PV curve from the FE model and the analytical expression (Klotz
et al., 2006). The sequential least squares (SLSQP) algorithm
(Jones et al., 2001) was used in the Python script, and ABAQUS
was used for the FE modeling, as the forward solver (Table 1 and
Figure 2).
The formulation for the active stress has been described
extensively in the literature (Guccione and McCulloch, 1993;
Walker et al., 2005; Genet et al., 2014; Sack et al., 2016). In short,
the active stress in the myofiber direction was calculated as:
T0 = Tmax
Ca20
Ca20 + ECa
2
50
Ct (2)
TABLE 1 | Passive material properties that produced a pressure-volume curve
close to the experimental pressure-volume curve (Figure 2).
a
(MPa)
b af
(MPa)
bf as
(MPa)
bs afs
(MPa)
bfs
6.832e−4 7.541 2.252e−3 14.471 3.127e−4 12.548 1.837e−4 3.088
FIGURE 2 | The passive material properties were determined such that the
end diastolic pressure volume (ED PV) curve from finite element model was
close to the experimental ED PV curve determined by Klotz et al. (2006).
where Tmax is the isometric tension at the largest sarcomere
length and highest calcium concentration, Ca0 is the peak
intracellular calcium concentration, and
Ct =
1
2
(1− cosω),
ω =


π tt0
when 0 ≤ t ≤ t0
π t−t0+trtr
when t0 ≤ t ≤ t0 + tr
′
0 when t ≥ t0 + tr
tr = ml+ b
m, b = constants that govern the shape of the linear relaxation
duration and sarcomere length relaxation.
Also,
ECa50 =
(Ca0)max√
exp
[
B
(
l− l0
)]
− 1
, l = lR
√
2Ef f + 1
where Ef f is the Lagrangian strain in the fiber direction, B is a
constant that governs the shape of the peak isometric tension-
sarcomere length relation, l0 is the sarcomere length that does not
produce active stress, lR is the sarcomere length with the stress-
free condition, and (Ca0)max is the maximum peak intracellular
calcium concentration.
The active stress was added to the passive stress to compute
total stress:
S = SPassive + T (3)
where S is the total stress.
The boundary and load conditions generally follow
the ABAQUS Living Heart Model (Baillargeon et al., 2014,
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2015; Sack et al., 2016). In particular, the center of the LV
proximal cross-section (base) was fixed. The average rotation
and translation of nodes of the endocardial annulus were coupled
to the center of the LV base. This boundary condition prevents
rigid body rotation, but allows inflations and contractions of the
annulus. The nodes of the base were fixed in the longitudinal
direction. A pressure load was applied to the LV surface to
simulate diastole, whereas the contraction of the LV muscles
caused systole. Surface-based fluid cavities and fluid exchanges
were used to model blood flow (ABAQUS Analysis User’s
Guide).
When Tmax is changed in Equation (2), the total contractile
force of the tissue is altered, and other parameters related
to the passive and active material formulations (Equations 1,
2) either do not change or change in a consistent way. We
can prescribe different values of Tmax in transmural layers to
introduce regionally varying contractility throughout the LV. We
considered six scenarios with different contractile properties, as
explained in Table 2. Homogenous contractile properties were
considered in scenario 1, which also served to establish a baseline
value for normal Tmax. Tmax was calibrated to produce the
echocardiogram-recorded value for end- systolic volume (ESV)
for this patient (24.8ml). To simulate the diseased condition,
subendocardial contractility was set to zero by setting Tmax = 0
(scenario 2). To recover ESV, a scenario was considered in which
Tmax was increased in the subepicardial layers (scenario 3). To
further assess the effects of transmural contractility, three more
scenarios with different contractility in the transmural layers
were created. In scenario 4, Tmax in all regions was reduced by
50%. In scenario 5, Tmax was set to zero in subepicardial and
midmyocardial regions. In scenario 6, Tmax was set to zero in the
subepicardial region.
To calculate LV torsion, we use the following formula (Aelen
et al., 1997; Rüssel et al., 2009).
τ =
(Øapex −Øbase)× (ρapex + ρbase)
2D
(4)
Where τ is normalized LV torsion; Øapex and Øbase are rotations
in the apex and base, respectively; ρapex and ρbase are the radius
of the apex and base, respectively; and D is the distance between
the apex and base (Figure 3).
RESULTS
The EF decreased from 53.2 to 40.5% when Tmax was set to
zero in the subendocardial layers (Table 2 and Figure 4: scenario
2 vs. 1: 23.9% reduction in EF). The depressed contractility in
the subendocardial region was enough to drop EF below 50%,
producing HF with reduced EF (HFrEF). The EF normalized
FIGURE 3 | The torsion of the LV was computed based on the apical and
basal rotations, the apical and basal radius, and the distance between the
apex and base. The formula used to compute the LV torsion (Equation 4)
makes the LV torsion comparable for hearts of different sizes (Aelen et al.,
1997; Rüssel et al., 2009). The positive rotation is counterclockwise when
seen from apex.
TABLE 2 | Six scenarios were created to examine effects of contractility (Tmax) on EF.
Scenario Tmax
(MPa)
EF
(%)
ESV
(ml)
ESP
(mmHg)
Torsion
(degrees)
Strain
(%)
Three inner layers
(subendocardium)
Two middle layers
(midmyocardium)
Three outer layers
(subepicardium)
El Ec Er
1 0.086 0.086 0.086 53.2 24.7 88.9 24.7 −8.5 −29.7 44
2 0.0 0.086 0.086 40.5 31.4 94.5 26.7 −4.5 −15.8 25.3
3 0.0 0.086 0.117 53.2 24.7 92.8 30.2 −6.1 −28.1 39.9
4 0.043 0.043 0.043 13.3 45.8 82.6 18.6 −5.7 −0.6 12.9
5 0.086 0.0 0.0 0.3 52.6 63.2 −7.6 −7.6 2.7 4.9
6 0.086 0.086 0.0 12.7 46.0 80.1 −13.0 −5 −4.4 7.15
Scenario 1 represents the normal condition; scenario 2 represents zero subendocardial contractility; scenario 3 represents zero subendocardial contractility and increased subepicardial
contractility (an HFpEF condition); scenario 4 represents decreased contractility in all regions; scenario 5 represents zero midmyocardial and subepicardial contractility, and scenario 6
represents zero subepicardial contractility. For scenario 1, the computational EF matched the experimental EF. For all scenarios, EDV = 53ml, EDP = 14.3 mmHg. El, Ec, and Er are,
respectively, ES strain in longitudinal, circumferential and radial directions. The circumferential and radial strains were computed using the nodes located at the endocardial annulus
(base of the LV).
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FIGURE 4 | When the subendocardial contractility was zero, EF reduced by
23.9% relative to scenario 1 (scenarios 1 and 2). Increased subepicardial
contractility recovered EF to scenario 1 (scenarios 1 and 3).
when Tmax was increased in the subepicardial layers (Table 2
and Figure 4: scenario 3 vs. 1). This increased subepicardial
contractility was enough to recover EF from the failing value of
40.5% and reach 53.2% (vs. 53.2% in the normal scenario). End-
systolic pressure (ESP) and ESV increased when subendocardial
contractility was zero. After subepicardial contractility increased,
ESV and ESP decreased (Table 2, scenario 3 vs. 1 and 2).
The EF decreased by 75% when contractility decreased by
50% in all layers (Table 2: scenario 4 vs. 1). When subepicardial
and midmyocardial contractility was zero, EF became almost
zero (0.3% in scenario 5, Table 2). Similarly, when subepicardial
contractility was zero, EF decreased dramatically compared
to the normal scenario (12.7% in scenario 6 vs. 53.2% in
scenario 1, Table 2). ESV noticeably increased and ESP decreased
in scenarios 4, 5, and 6 vs. scenario 1.
When subendocardial contractility was zero, LV torsion
increased (scenario 2 vs. 1). The torsion further increased after
contractility in a remaining region was increased to compensate
(scenario 3 vs. 1 and 2). The torsion decreased when contractility
in all transmural regions decreased by 50% (scenario 4 vs. 1).
The torsion reversed when midmyocardial and subepicardial
contractility were decreased to zero (scenario 5 vs. 1). The
reversed torsion increased when only subepicardial contractility
was zero (scenario 6 vs. 5).
Strains (which are independent of displacement boundary
conditions) were altered in diseased conditions. The global
longitudinal, circumferential, and radial strains decreased in
HFpEF, but recovered after subepicardial contractility increased
(Table 2, scenarios 2 and 3 vs. scenario 1). In addition, the
global strains decreased when contractility decreased by half in all
layers, and when subepicardial and midmyocardial contractility
were zero, and also when subepicardial contractility was zero
(Table 2, scenarios 4, 5, and 6 vs. scenario 1). The direction
of circumferential strain changed when midmyocardial and
subepicardial contractility were both zero (Scenario 5 vs. 1,
Table 2). With normal homogenous contractility (scenario 1),
FIGURE 5 | A long-axis view showing that at end systole, with uniform Tmax
(scenario 1), all layers experienced compressive strain in myofiber directions.
When subendocardial contractility was zero, the strain pattern was altered
(scenarios 1 and 2), but it partially recovered when subepicardial contractility
increased (scenarios 1 and 3).
all layers experienced contractile strains (Figures 5–7). Regional
changes in contractility to simulate HFrEF (scenario 2) and
HFpEF (scenario 3) both presented with tensile strains in
the subendocardial regions where contractility was set to zero
(Figures 5–7). However, the increased subepicardial contractility
in HFpEF had a global effect on strains throughout all layers,
reducing the strains in all regions. Qualitatively, the transmural
strain curve of the HFpEF case (scenario 3) replicated the
pathological HFrEF curve (scenario 2), albeit with strains that
were 23.8% lower on average.
ES stress in the myofiber direction was noticeably reduced
when subendocardial contractility decreased (scenarios 1 and
2, Figure 8). A trend to recovery in the stress distribution was
observed when subepicardial contractility increased (scenarios 1
and 3, Figure 8).
The ES-shortening longitudinal displacement of the LV
was profoundly decreased when subendocardial contractility
was zero (scenarios 1 and 2, Figure 9). The longitudinal
displacement was partially recovered when subepicardial
contractility increased (scenarios 1 and 3, Figure 9).
The ES sphericity index (defined as the ratio between the
lengths of the LV long axis and the short axis) was approximated
as 1.1, 1.0, and 1.1 for scenarios 1, 2, and 3, respectively. In
the HFrEF case (scenario 2), the ES sphericity index decreased
compared to scenario 1. However, the ES sphericity index in
the HFpEF scenario normalized toward the normal scenario. In
other words, when the subendocardial contractility was zero, the
LV shape became more spherical, compared to scenario 1. The
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FIGURE 6 | A short-axis view showing that the ES myofiber strain pattern
altered when subendocardial contractility was zero (scenarios 1 and 2), but a
partial recovery in strain pattern was observed when subepicardial contractility
increased (scenarios 1 and 3).
FIGURE 7 | The ES myofiber strain at various points along LV thickness. In the
horizontal axis, 0% represents the endocardium and100% represents the
epicardium. The alterations in strains in scenario 2 are noticeable, compared
to scenario 1. In scenario 3, the tensile strains decreased compared to
scenario 2.
shape of the LV recovered toward the normal scenario when
subepicardial contractility increased.
DISCUSSION
In this study, we used a realistic FE model of the human LV to
examine the role of altered LV systolic mechanics as a mechanism
FIGURE 8 | A long-axis view showing the ES myofiber compressive stress
decreased when the subendocardial contractility was zero (scenarios 1 and 2).
The stress pattern became partially similar to the normal case when
subepicardial contractility increased (scenarios 1 and 3).
FIGURE 9 | The ES longitudinal deformation was altered when subendocardial
contractility was zero (scenarios 1 and 2). Deformation partially recovered
when subepicardial contractility increased (scenarios 1 and 3).
of HFpEF. Our findings support the hypothesis that HFpEF
could be a result of lower subendocardial contractility linked
with increased subepicardial contractility (Sengupta and Narula,
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2008; Shah and Solomon, 2012; Omar et al., 2016, 2017). When
subendocardial contractility was zero, LVEF decreased by 23.9%
(Table 2: 53.2% in scenario 1 vs. 40.5% in scenario 2). The EF
normalized when subepicardial contractility increased (Table 2:
53.2% in scenario 3 vs. 53.2% in scenario 1). The change in
subepicardial contractility (less than a 40% increase from normal
values) resulted in a 31.4% improvement in EF. Unlike scenario
1, scenarios 2 and 3 experienced abnormal strains within the
subendocardial region (Figures 5–7), even though scenario 3
experienced normal EF. The ES sphericity index decreased in
scenario 2 (1.0) compared to scenario 1 (1.1), but it recovered
in scenario 3 (1.1). The LV torsion increased in scenario 2
(26.7◦) compared to scenario 1 (24.7◦), and it further increased
in scenario 3 (30.2◦).
The subendocardial region played an important role in the
LV systolic mechanics, as our results showed. In particular, when
subendocardial contractility was zero, the EF was reduced below
50%. A scenario with EF below 50% and zero subendocardial
contractility corresponds to HFrEF (Vasan et al., 1999; Owan and
Redfield, 2005; Yancy et al., 2013). Also, reducing EF below 50%
by zeroing subendocardial contractility is in line with previous
studies that reported the important role of the subendocardial
region in the mechanics of the LV (Sabbah et al., 1981; Algranati
et al., 2011). Based on our adopted definition of end-systolic
elastance (EES) (Chen et al., 2001), our results imply that EES
decreased after subendocardial contractility was zero, but EES
recovered when subepicardial contractility increased (Table 2,
scenarios 2 and 3 vs. scenario 1). Increased ESP in HFpEF could
be due to alterations in the ejection period of the LV (scenario
2). After subendocardial contractility was lost, the ejection period
shortened and ended with a higher pressure.
The EF decreased by 75%when contractility decreased by 50%
in all layers (scenario 4 vs. scenario 1, Table 2). On the other
hand, setting subepicardial and midmyocardial contractility
to zero affected EF more than subendocardial contractility
(0.3% in scenario 5 and 12.7% in scenario 6 vs. 40.5% in
scenario 2, Table 2). This result illustrates the important role of
subepicardial and midmyocardial regions and confirms previous
experimental (Haynes et al., 2014) and computational (Wang
et al., 2016) studies that indicated the important roles of the
epicardium and midmyocardium in systolic mechanics of the
LV. Also, based on our adopted definition of EES, this parameter
decreased when contractility decreased in all layers by 50%, and
when subepicardial and midmyocardial contractility were zero,
and also when subepicardial contractility was set to zero (Table 2,
scenarios 4, 5, and 6 vs. scenario 1).
Quantifying changes in torsional deformation related to
changes in transmural contractility revealed an interesting
relationship between the two. Abnormally high torsion could be
a useful index of pathology, as we showed when subendocardial
contractility was lost (Table 2, scenarios 2 and 3 vs. 1). This
result confirms previous reports according to which the LV
torsion increases in subendocardial ischemia (Prinzen et al.,
1984), which has been related to the counter torque applied
by the subendocardial region against the subepicardial region
(Aelen et al., 1997). Also, this counter torque effect between
subendocardium and subepicarium can be seen in scenarios
5 and 6 (Table 2). In these scenarios a negative torsion was
seen after midmyocardium and subepicardium contractility was
set to zero. The torsion of the LV is strongly coupled to the
LV contractility and the inability to complete ejection properly
(Table 2).
The longitudinal strain has been reported as a criterion
to diagnose normal and diseased hearts (Henein and Gibson,
1999; Takeda et al., 2001; Yu et al., 2002; Vinereanu et al.,
2005). The decreased longitudinal strain in our results (Table 2)
corresponds to clinical studies that reported longitudinal strains
decrease in HFpEF (Mizuguchi et al., 2010). Also, the contour
of ES longitudinal displacement, which is directly related to
longitudinal strain, was noticeably altered in the diseased
scenario compared to the normal scenario (Figure 9, scenarios
1 and 2). However, when subepicardial contractility increased,
the pattern of longitudinal displacement became more similar
to the normal scenario (Figure 9, scenarios 1 and 3). The ES
strain pattern across the regional layers of the LV wall (Figure 7)
also supported the hypothesis that increased subepicardial
contractility in HFpEF improves function globally (Sengupta
and Narula, 2008). Moreover, the alterations in circumferential
and radial strains are in line with clinical studies that reported
these strains decrease in HFpEF (Wang et al., 2008; Mizuguchi
et al., 2010). Yet, our results should be interpreted with caution.
The circumferential and radial strains for normal conditions
(scenario 1) were in line with clinical data reported in the
literature, whereas the longitudinal strain was smaller than
reported clinical data (Moore et al., 2000; Yingchoncharoen et al.,
2013). The methodology of our study is similar to previous
computational models of LV in our group. The longitudinal
strain results of these previous models have been validated
against experimental strain data (for example, Genet et al., 2014).
It has been well-documented that the shape of the LV changes
in HF (Grossman et al., 1975; Carabello, 1995; Gaasch and Zile,
2011). In particular, LV concentric hypertrophy is seen in patients
with HFpEF (Melenovsky et al., 2007), and exercise capacity is
correlated with the sphericity index of the LV (Tischler et al.,
1993). In line with previous studies, in our simulations, the
shape of the LVwas altered when the subendocardial contractility
was zero. The ES sphericity index decreased in scenario 2 (1.0)
compared to scenario 1 (1.1). When subepicardial contractility
increased, the shape of the LV recovered toward the normal case,
as seen in the ES sphericity index in scenario 3 (1.1) compared
to scenario 2 (1.0). Thus, the increased subepicardial contractility
may prevent LV dilatation in HFpEF, and help preserve the LV
shape. This phenomenon will further support the normalization
of LVEF due to the direct interplay between the LV shape and
function (Grossman et al., 1975; Stokke et al., 2017).
In this study we used tissue-level load-independent properties
(Tmax) to alter myocardium contractility. This approach is more
appropriate than using the LV strains. In fact, the popular notion
of equating myocardial contractility with strain measurements
(that are load dependent) is “off the mark [and] if contractility
means anything, it is as an expression of the ability of a given
piece of myocardium to generate tension and shortening under
any loading conditions” (Reichek, 2013). Therefore, our approach
to alter transmural contractility, which might not be feasible
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using current experimental methods, could lead to a better
understanding of the development of HFpEF.
Novel physics-based mathematical modeling was used in this
study to examine a possible mechanism underlying preservation
of LVEF in HFpEF. The results from the simulations provide
evidence of the potential role of myocardial contractility in
the genesis of preserved EF in the HFpEF phenotype. Previous
studies on HFpEF were mostly based on experimental data
(for example, Phan et al., 2009), where the contribution of a
single feature like myocardial contractility could not be varied
in isolation of other parameters. However, we used FE modeling
to simulate and isolate transmural contractility as a feature
and study its effect on LV systolic mechanics. Our results
provide important first steps toward eventual development of a
computational model of HFpEF.
Study Limitations and Future Directions
The simulation addressed only the relationship between
transmural myocardial contractility and LV systolic mechanics.
Modeling all aspects of HFpEF was beyond the scope of this
paper. In clinical conditions, several factors contribute to the
development of HFpEF (Bench et al., 2009; Shah and Solomon,
2012; Sengupta and Marwick, 2018). These factors include
abnormalities in both the systolic and the diastolic mechanics
of the LV (MacIver and Townsend, 2008; MacIver, 2009; Shah
and Solomon, 2012), the LV hypertrophy and geometric changes
(Aurigemma et al., 1995; Vasan et al., 1999; Adeniran et al.,
2015) and material properties of the LV (stiffness). A recent study
employed computational models with heterogeneous transmural
distributions of Tmax (Wang et al., 2016). In our investigation,
only in one scenario (scenario 1) did we assume Tmax to be
uniform in the transmural direction. Also, since this study
focused on the LV, we assumed timing and activation of
contractility are homogenous. Amore realistic assumption would
be to consider the sequence of electrical stimulations in the tissue
(Chabiniok et al., 2012; Villongco et al., 2014; Crozier et al., 2016;
Giffard-Roisin et al., 2017), particularly in the septum. However,
a heterogeneous distribution of Tmax would be more important if
atria were also included in themodel. Moreover, we onlymodeled
LV data from one human subject in our study. Modeling data
from multiple subjects is the goal of a subsequent study. Here,
our intent was to document our modeling methodology and
demonstrate its utility.
Alterations in strain distributions might lead to remodeling in
the LV tissue (Figures 5–7). The response of myocardial tissue
to an altered mechanical environment will likely lead to changes
in tissue properties that will in turn affect the LV inflation,
contraction, and relaxation. It is well-documented that diastolic
LV tissue stiffness becomes abnormally high in HFpEF (Zile
et al., 2004). Our study focused on the systolic mechanics of
the LV. As a future direction, integration of tissue response in
diastole and systole will provide a more realistic and informative
model to understand the mechanisms involved during the onset
and development of HFpEF. Integration of cell-based cross-
bridge cycling and contractility could provide more realistic
information about the tissue alterations over the course of HFpEF
development (Adeniran et al., 2015; Shavik et al., 2017).
Although our study explored a simplified representation of
HFpEF (appropriately so, to isolate mechanical effects), the
clinical definition and diagnosis of HFpEF and HFrEF are more
complex than just calculations of EF (Borlaug and Paulus, 2011).
In fact, HFpEF lacks a clear validated diagnostic guideline (Lam,
2010; Oghlakian et al., 2011). In this hypothesis-generating
study, we simply assumed EF < 50% represents HFrEF. This
assumption is in line with some definitions used for HFrEF in
the literature (Vasan et al., 1999; Paulus et al., 2007). However,
an EF = 40.5% (scenario 2) might also be defined as borderline
HFpEF (for example, Yancy et al., 2013). These points may be
considered semantic because they do not affect the conclusions
of our study, which quantified alterations in contractility with
changes in EF, torsion and strain. It would be interesting to apply
these methods to personalized models derived from patients
diagnosed clinically with HFpEF and HFrEF.
Several other scenarios need to be investigated, including
more graded loss of subendocardial contractility, and graded
decrease of subendocardial contractility, with both coupled
to a graded increase in subepicardial contractility. Moreover,
the definitions of subendocardium, midmyocardium, and
subepicardium regions were arbitrary in this study because
exact definitions are not available. A more realistic imaging
approach might better delineate transmural layers and their
related contractility. Furthermore, exercise intolerance has been
reported as a key factor in HFpEF (Roh et al., 2017), and
could be implemented in our modeling methodology to better
understand the mechanisms of HFpEF development. Despite
these limitations, this paper reports instructive quantitative
information about development of HFpEF, as we could change
one aspect of the model (contractility at a particular location) and
determine its effects alone.
CONCLUSIONS
The results of this study support the hypothesis that preservation
of LVEF in patients with HFpEF could be explained on the basis
of reduced subendocardial contractility with a compensatory
increase in subepicardial contractility. These findings underscore
the roles of regional LVmyocardial contractility inHF syndromes
and emphasize the importance of computational models
in understanding pathophysiological mechanisms underlying
complex phenotypic presentations like HFpEF.
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